MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-04-0014889
Ntmed Pharmaceuticals Private Limited
Ntmed Pharmaceuticals Private Limited - pharma in Aurangabad, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.15 Cr
▲ 11% YoY
Net profit · FY 2025
₹40,000
Net margin 0.3%
EBITDA · FY 2025
₹4.12 Lakh
EBITDA margin 3.6%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Satisfied charges
₹10 Lakh
No open charges
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
About Ntmed Pharmaceuticals Private Limited
Data last updated:
Ntmed Pharmaceuticals Private Limited is a private limited company based in Aurangabad, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 04 November 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U52190MH2020PTC349391. Its GSTIN is 27AAHCN2622F1ZO (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Chhaya Ravindra Sonavane and Ravindra Deoram Sonawane.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No/P – 17 Gala No. 231 MIDC Shrndra, Aurangabad, Maharashtra, India – 431007.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.15 Cr, a growth of 11% compared to the previous year. For the same year it recorded a net profit of ₹40,000 (net margin 0.3%) and EBITDA of ₹4.12 Lakh (EBITDA margin 3.6%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years.
As per MCA filings, the company has satisfied charges of ₹10 Lakh on record.
Ntmed Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-04-0014889).
Company details
CIN U52190MH2020PTC349391
Registration Number 349391
Incorporation Date 04 November 2020
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-MH-04-0014889
Recognitions & Rankings of Ntmed Pharmaceuticals
Contact details
Ntmed Pharmaceuticals Private Limited's registered office is in Aurangabad, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No/P – 17 Gala No. 231 MIDC Shrndra, Aurangabad, Maharashtra, India – 431007
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Ntmed Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Ntmed Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Ntmed Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Ntmed Pharmaceuticals Private Limited, buy the company report.
Financials of Ntmed Pharmaceuticals Private Limited
FY 2025 filings availableNtmed Pharmaceuticals Private Limited reported revenue of ₹1.15 Cr (up 11% YoY) for FY 2025.
Revenue · FY 2025
₹1.15 Cr ▲ 11%
Net profit · FY 2025
₹40,000 margin 0.3%
EBITDA · FY 2025
₹4.12 Lakh margin 3.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 11%
3 years · compounded
▲ 5%
EBITDA CAGR growth
1 year
▼ 12%
3 years · compounded
▼ 4%
Revenue has grown at a compounded annual rate (CAGR) of 5% over three years, including 11% growth in the latest year. EBITDA fell 12% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.12 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹40,000 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.6% | ||||
| Net Profit Margin | 0.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ntmed Pharmaceuticals Private Limited, buy the company report.
Board of directors of Ntmed Pharmaceuticals Private Limited
Ntmed Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chhaya Ravindra Sonavane | Director | 04 Nov 2020 | 5 Years 11 Months | Current |
| Ravindra Deoram Sonawane | Director | 04 Nov 2020 | 5 Years 11 Months | Current |
Auditor
Ntmed Pharmaceuticals Private Limited is audited by YADKIKAR&CHANDAK for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| YADKIKAR&CHANDAK | FY 2022 | 129599W |
Shareholding
The shareholding of Ntmed Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Ntmed Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
None
Satisfied charges
₹10 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 14 May 2021 | 100451361 | Others | ₹10 Lakh | Satisfied |
To see the full charge records of Ntmed Pharmaceuticals Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Ntmed Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ntmed Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Ntmed Pharmaceuticals Private Limited has 1 active EPFO establishment as of Apr 06, 2024.
Active EPFO establishments
1
GST
Ntmed Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAHCN2622F1ZO | Maharashtra | Active | 10 Dec 2020 |
To see the full GST registrations and return filing status of Ntmed Pharmaceuticals Private Limited, buy the company report.
Recent activity
Ntmed Pharmaceuticals Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Chhaya Ravindra Sonavane was appointed as Director on 04 Nov 2020.
AGM
Ntmed Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Ntmed Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii.
Charges
A charge registered on 14 May 2021 via Charge ID 100451361 with Others was fully satisfied on 04 Feb 2022.
Charges
A charge with Others amounted to Rs. 10.00 Lakh with Charge ID 100451361 was registered on 14 May 2021.
Appointed
Chhaya Ravindra Sonavane was appointed as Director.
Appointed
Ravindra Deoram Sonawane was appointed as Director.
Incorporation
04 Nov 2020
Ntmed Pharmaceuticals Private Limited was registered on 04 Nov 2020 with Roc Mumbai Ii & aged 5 years 11 months as per MCA records.
Frequently asked questions
Ntmed Pharmaceuticals is an active private limited company based in Aurangabad, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 04 November 2020 (6+ years old) and is registered under CIN U52190MH2020PTC349391.
Ntmed Pharmaceuticals has 2 current directors:
- Chhaya Ravindra Sonavane - Director
- Ravindra Deoram Sonawane - Director
The latest financial statements of Ntmed Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Ntmed Pharmaceuticals is 27AAHCN2622F1ZO, registered in Maharashtra.
The CIN (Corporate Identification Number) of Ntmed Pharmaceuticals is U52190MH2020PTC349391. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ntmed Pharmaceuticals was incorporated on 04 November 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
Chhaya Ravindra Sonavane was appointed as Director on 04 Nov 2020. Ravindra Deoram Sonawane was appointed as Director on 04 Nov 2020.
Yes, Ntmed Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-04-0014889).
The registered office of Ntmed Pharmaceuticals is at Plot NoP – 17 Gala No. 231 MIDC Shrndra, Aurangabad, Maharashtra, India – 431007.
Ntmed Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.